Skip to main content
. Author manuscript; available in PMC: 2011 Nov 1.
Published in final edited form as: Pharmacogenet Genomics. 2010 Nov;20(11):665–676. doi: 10.1097/FPC.0b013e32833f2cd0

Figure 2. mRNA expression by QPCR of the 6 genes selected for genotyping in ‘best’ responder JIA patients, comparing before and after MTX treatment.

Figure 2

Bars show mean expression levels relative to beta2 microglobulin (B2M) gene expression, pre- (white bars) and post- (black bars) MTX; error bars indicate 1 standard error of the mean. Significant differences (p < 0.05) between pre- and post- MTX are indicated by *.